Reply: The A2 milk case: A critical review [2]

European Journal of Clinical Nutrition

Volumn 60, Issue 7, 2006, Pages 924-925

  Truswell, A S ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CASEIN; BETA CASEIN A1; BETA CASEIN A2; BETA CASOMORPHINE; BETA CASOMORPHINE 7; BETA CASOMORPHINE DERIVATIVE; CASEIN; MILK PROTEIN; UNCLASSIFIED DRUG;

ARTIFICIAL MILK; ATHEROSCLEROSIS; AUTISM; CHRONIC DISEASE; CLINICAL TRIAL; DIABETES MELLITUS; FOOD INTAKE; GLUTEN FREE DIET; HUMAN; INFANT NUTRITION; INSULIN DEPENDENT DIABETES MELLITUS; ISCHEMIC HEART DISEASE; LETTER; MILK; NONHUMAN; NUTRITIONAL ASSESSMENT; PATHOPHYSIOLOGY; PROTEIN METABOLISM; SCHIZOPHRENIA;

EID: 33745712856     PISSN: 09543007     EISSN: 14765640     Source Type: Journal    
DOI: 10.1038/sj.ejcn.1602454     Document Type: Letter

References (4)

1. Svedberg J, de Haas J, Liemenstoff G, Paul P, Teschemacher H (1985). Demonstration of B-casomorphin immunoreactive materials in In Vitro digests of bovine milk and in small intestine contents after bovine milk ingestion in adult humans. Peptides 6, 825-830.
2. Chin-Dusting J, Shennan J, Jones E, Williams C, Kingwell B, Dart A (2006). Effect of dietary supplementation of beta casein A1 or A2 on markers of disease development in individuals at high risk of cardiovascular disease. Br J Nutr 95, 135-144.
3. Venn BJ, Skeaff CM, Brown R, Mann JI, Green TJ (2006). A comparison of the effects of A1 and A2 beta-casein protein variants on blood cholesterol concentrations in New Zealand adults. Atherosclerosis, in press.
4. Muntoni S, Muntoni S (2006). Epidemiological association between some dietary habits and the increasing incidence of type 1 diabetes worldwide. Ann Nutr Metab 50, 11-19.